Anthony Welters - 26 Aug 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Aug 2026, 18:44:48 UTC
Prior SEC filing
01 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy Kim by Power of Attorney for Anthony Welters

Key filing fact

Anthony Welters filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 27 Aug 2026.

Key facts

  • This page summarizes Anthony Welters's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
  • 8 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 27 Aug 2026, 18:44.

Change

  • Previous filing in this sequence was filed on 01 May 2026.
  • Current net transaction value: -$2,675,220.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001213307 Primary reporting owner

WELTERS ANTHONY

Relationship
Director
Address
333 LAKESIDE DRIVE, FOSTER CITY
Signature
/s/ Amy Kim by Power of Attorney for Anthony Welters
Signature date
27 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Options Exercise

Transaction value
Shares
+7,718
Change %
+60%
Price
$60.67*
Shares after
20,612
Date
26 Aug 2026
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Sale

Transaction value
$462,432
Shares
-3,118
Change %
-15%
Price
$148.31
Shares after
17,494
Date
26 Aug 2026
Ownership
Direct
Footnotes
F1, F2
GILD transaction

Common Stock

Sale

Transaction value
$684,590
Shares
-4,600
Change %
-26%
Price
$148.82
Shares after
12,894
Date
26 Aug 2026
Ownership
Direct
Footnotes
F1, F3
GILD transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,282
Change %
+80%
Price
$61.35*
Shares after
23,176
Date
26 Aug 2026
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Sale

Transaction value
$504,296
Shares
-3,402
Change %
-15%
Price
$148.24
Shares after
19,774
Date
26 Aug 2026
Ownership
Direct
Footnotes
F1, F4
GILD transaction

Common Stock

Sale

Transaction value
$1,023,900
Shares
-6,880
Change %
-35%
Price
$148.82
Shares after
12,894
Date
26 Aug 2026
Ownership
Direct
Footnotes
F1, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-7,718
Change %
-100%
Price
$0.000000*
Shares after
0
Date
26 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,718
Exercise price
$60.67
Footnotes
F1, F6
GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-10,282
Change %
-65%
Price
$0.000000*
Shares after
5,569
Date
26 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,282
Exercise price
$61.35
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.

Footnote F2

Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F3

Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F4

Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F5

Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F6

100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.

Footnote F7

25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .